Pharming Group N.V. - ADR

XNAS:PHAR 4:00:00 PM EDT

13.41

-0.35 (-2.54%)

4:10:04 PM EDT: $13.41 0.00 (0.00%)

Market Cap (Intraday)	895.45M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$98.22 Million
Adjusted EPS	$0.00

See more estimates

10-Day MA	$13.75
50-Day MA	$14.33
200-Day MA	$10.85

See more pivots

Pharming Group N.V. - ADR Stock, XNAS:PHAR

Vondellaan 47, Leiden, Zuid-Holland 2332 AA

Netherlands

Phone: +31.71.524.74.00

Number of Employees:

http://www.pharming.com

Description

Pharming Group NV is a holding company, which engages in the development of pharmaceutical products for the treatment of rare diseases and unmet medical needs. The firm offers RUCONEST, which is a recombinant human C1-esterase inhibitor for the treatment of acute hereditary angioedema. It operates through the following segments: RUCONESTÃ?Â®, JoenjaÃ?Â®, Europe, and Rest of the World. The company was founded on November 11, 1988, and is headquartered in Leiden, the Netherlands.